Phase II, Open-label, Loading and Maintenance Dose Finding Study of GTx-758 in Men With Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2013
At a glance
- Drugs GTx 758 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 08 Mar 2012 Actual patient number added 43 according to ClinicalTrials.gov.
- 27 Feb 2012 Status changed from suspended to discontinued.
- 21 Feb 2012 This trial was suspended, according to a GTx media release.